RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.

Authors :: Bertucci F
de Nonneville A
Finetti P
Mamessier E
Source :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Jun 08; Vol. 115 (6), pp. 762-763.
Publication Year :: 2023

Subjects :: Humans
Female
Ado-Trastuzumab Emtansine
Receptor, ErbB-2 metabolism
RNA, Messenger genetics
Trastuzumab therapeutic use
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms drug therapy
Breast Neoplasms genetics
Maytansine therapeutic use

Full Text Access

Tools